Save your place

Sign in to WhoBought

Please try again later.

Pacira BioSciences, Inc. (PCRX) institutional ownership

Market cap$1.0B SectorHealthcare
Funds holding · Q1 2026
239
reported PCRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
113 buyers · 126 sellers

Pacira BioSciences, Inc. (PCRX) price and institutional activity

Dates

Q1 2026

$0 bought by 113 investors
Goldman Sachs Group IncMorgan Stanley +111 more
$0 sold by 126 investors
Balyasny Asset Management L.P.American Century Companies Inc +124 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Pacira BioSciences, Inc. (PCRX) institutional activity · 239

Investor Type Est. change Change Δ Own Date
Balyasny Asset Management L.P. · Reduced
Change −840K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −840K Q1 2026
American Century Companies Inc · Reduced
Change −498K Date Q1 2026
American Century Companies Inc Reduced· Q1 2026 −498K Q1 2026
Assenagon Asset Management S.A. · Exited
Change −435K Δ Own −100.0% Date Q1 2026
Assenagon Asset Management S.A. Exited· Q1 2026 −435K −100.0% Q1 2026
J. Goldman & Co LP · Reduced
Change −339K Date Q1 2026
J. Goldman & Co LP Reduced· Q1 2026 −339K Q1 2026
BlackRock · Reduced
Change −329K Date Q1 2026
BlackRock Reduced· Q1 2026 −329K Q1 2026
Healthcare of Ontario Pension Plan Trust Fund · Exited
Change −304K Δ Own −100.0% Date Q1 2026
Healthcare of Ontario Pension Plan Trust Fund Exited· Q1 2026 −304K −100.0% Q1 2026
Goldman Sachs Group Inc · Added
Change +270K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +270K Q1 2026
Jane Street Group, LLC · Reduced
Change −246K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −246K Q1 2026
Voloridge Investment Management, LLC · Reduced
Change −215K Date Q1 2026
Voloridge Investment Management, LLC Reduced· Q1 2026 −215K Q1 2026
Morgan Stanley · Added
Change +200K Date Q1 2026
Morgan Stanley Added· Q1 2026 +200K Q1 2026
Lsv Asset Management · Added
Change +197K Date Q1 2026
Lsv Asset Management Added· Q1 2026 +197K Q1 2026
Pacer Advisors, Inc. · Exited
Change −189K Δ Own −100.0% Date Q1 2026
Pacer Advisors, Inc. Exited· Q1 2026 −189K −100.0% Q1 2026
Nuveen, LLC · Reduced
Change −162K Date Q1 2026
Nuveen, LLC Reduced· Q1 2026 −162K Q1 2026
Vanguard · Reduced
Change −139K Date Q1 2026
Vanguard Reduced· Q1 2026 −139K Q1 2026
Intech Investment Management LLC · Reduced
Change −136K Date Q1 2026
Intech Investment Management LLC Reduced· Q1 2026 −136K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 239

Famous investor activity in Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences, Inc. (PCRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Riker Lauren · Officer Sell −$144K
Price $23.50 Qty −6K Owned 62K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Riker Lauren Officer Sell $23.50 −6K −$144K 62K Jun 11, 2026 Jun 12, 2026
Hirawat Samit · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Hirawat Samit Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Christie Christopher · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Christie Christopher Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Wiggans Thomas G. · Director Grant (A) 33K
Owned 33K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Wiggans Thomas G. Director Grant (A) 33K 33K Jun 10, 2026 Jun 12, 2026
Young Alethia · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Young Alethia Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Yang Michael J. · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Yang Michael J. Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Bigal Marcelo · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Bigal Marcelo Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Froimson Mark · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Froimson Mark Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Brege Laura · Director 2 operations 17K
Owned 11K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Brege Laura Director 2 operations 17K 11K Jun 10, 2026 Jun 12, 2026
Williams Kristen · Officer Sell −$228K
Price $22.27 Qty −10K Owned 167K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Williams Kristen Officer Sell $22.27 −10K −$228K 167K Jun 4, 2026 Jun 5, 2026
Riker Lauren · Officer Tax withholding or exercise payment (F) -$71K
Price $22.32 Qty -3K Owned 68K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Riker Lauren Officer Tax withholding or exercise payment (F) $22.32 -3K -$71K 68K Jun 3, 2026 Jun 5, 2026
Slonin Jonathan · Officer Tax withholding or exercise payment (F) -$106K
Price $22.32 Qty -5K Owned 219K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Slonin Jonathan Officer Tax withholding or exercise payment (F) $22.32 -5K -$106K 219K Jun 3, 2026 Jun 5, 2026
Williams Kristen · Officer Tax withholding or exercise payment (F) -$190K
Price $22.32 Qty -9K Owned 177K Trade date Jun 3, 2026 Filed date Jun 5, 2026
Williams Kristen Officer Tax withholding or exercise payment (F) $22.32 -9K -$190K 177K Jun 3, 2026 Jun 5, 2026
Cross Shawn · CFO Sell −$326K
Price $25.16 Qty −13K Owned 105K Trade date Apr 23, 2026 Filed date Apr 24, 2026
Cross Shawn CFO Sell $25.16 −13K −$326K 105K Apr 23, 2026 Apr 24, 2026
Cross Shawn · CFO 2 operations 0
Price $16.45 Owned 150K Trade date Apr 23, 2026 Filed date Apr 24, 2026
Cross Shawn CFO 2 operations $16.45 0 150K Apr 23, 2026 Apr 24, 2026
15 of 52
15 of 52 Sign in to continue to older insider transactions.

Pacira BioSciences, Inc. (PCRX) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 8.1M
% of shares outstanding 17.5% Filing date Jan 19, 2024
BlackRock Inc. 8.1M 17.5% Jan 19, 2024
Vanguard Group Inc 5.1M
% of shares outstanding 11.0% Filing date Feb 13, 2024
Vanguard Group Inc 5.1M 11.0% Feb 13, 2024
Vanguard Portfolio Management 2.6M
% of shares outstanding 6.4% Filing date May 1, 2026
Vanguard Portfolio Management 2.6M 6.4% May 1, 2026
Vanguard Capital Management 2.1M
% of shares outstanding 5.2% Filing date May 1, 2026
Vanguard Capital Management 2.1M 5.2% May 1, 2026
Baillie Gifford & Co 2.2M
% of shares outstanding 4.8% Filing date Mar 2, 2022
Baillie Gifford & Co 2.2M 4.8% Mar 2, 2022
Macquarie Group Ltd 2.0M
% of shares outstanding 4.4% Filing date Feb 14, 2023
Macquarie Group Ltd 2.0M 4.4% Feb 14, 2023
Renaissance Technologies LLC 1.8M
% of shares outstanding 4.2% Filing date Feb 10, 2022
Renaissance Technologies LLC 1.8M 4.2% Feb 10, 2022
7 of 7

Pacira BioSciences, Inc. (PCRX) ownership FAQ

Who owns PCRX?

239 reporting institutions disclosed PCRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.